Overview

Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effects of Ginkgo Biloba Extract (GBE) in executive function-impaired Mild Cognitive Impairment (MCI) patients by assessing gait while walking alone as well as under differing dual-task conditions. The primary endpoint in the evaluation of GBE efficacy is gait speed. The secondary endpoint is cycle time variability under dual-task conditions.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Basel, Switzerland